← Back to Search

N/A

DASH Diet for Heart Failure (DASH-HF Trial)

N/A

Waitlist Available

Led By Francene Steinberg, PhD

Research Sponsored by University of California, Davis

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Heart Failure diagnosis

Be older than 18 years old

Must not have

Uncontrolled arrhythmias or ischemia

End-stage renal disease or dialysis

Timeline

Screening 3 weeks

Treatment Varies

Follow Up probnp at 6 months

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing whether the DASH diet can help manage heart failure by looking at different ways the diet affects people.

Who is the study for?

This trial is for heart failure patients who have been on a stable, optimized medical regimen for at least 30 days. It's not suitable for individuals with a BMI under 18.5, those experiencing severe weight loss due to illness (cardiac cachexia), end-stage kidney disease or dialysis, ongoing inflammation, uncontrolled heart rhythm problems or ischemia, or those who've had a heart transplant or have an implanted heart pump.

What is being tested?

The study is examining the effectiveness of the DASH diet—a dietary approach to stop hypertension—in managing outpatient heart failure. Researchers will use behavioral assessments and clinical tests to measure how well this diet works in improving patient health.

What are the potential side effects?

Since the intervention involves dietary changes rather than medication, side effects may include nutritional imbalances if not properly followed. However, no specific side effects are directly associated with following the DASH diet as it promotes overall healthy eating.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with heart failure.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have irregular heartbeats or heart issues not managed by medication.

Select...

I have end-stage kidney disease or am on dialysis.

Select...

I am currently experiencing an acute inflammatory condition.

Select...

I have significant weight loss due to heart disease.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ dietary intake at 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~dietary intake at 6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and dietary intake at 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Blood Pressure

Diet score

Dietary intake

Secondary study objectives

Heart Failure clinical marker

Patient report of HF symptoms

Patient report of eating habit self efficacy

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Dietary Intervention ArmExperimental Treatment1 Intervention

Subjects will receive the active intervention of nutrition education and medical nutrition therapy counseling for dietary and behavioral lifestyle changes. The focus will be on DASH diet implementation and adherence for management of heart failure. The subjects will have 4 study visits with a Registered Dietitian over 6 months (visits at 1, 2, 3, and 6 months). Outcome measures will be assessed at baseline, 3 and 6 months.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

DASH diet

2010

Completed Phase 4

~1350

0 / 5Eligibility criteria met